Open Access

Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF‑κB and Wnt/β‑catenin signaling pathways

  • Authors:
    • Yuzhe He
    • Safwat Adel Abdo Moqbel
    • Langhai Xu
    • Jisheng Ran
    • Chiyuan Ma
    • Kai Xu
    • Jiapeng Bao
    • Lifeng Jiang
    • Weiping Chen
    • Yan Xiong
    • Lidong Wu
  • View Affiliations

  • Published online on: May 14, 2019     https://doi.org/10.3892/mmr.2019.10239
  • Pages: 312-322
  • Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Osteoarthritis (OA) is a chronic joint disease involving cartilage erosion and matrix degradation. Costunolide is a sesquiterpene lactone that has been demonstrated to exert anti‑inflammatory activities in a wide variety of cells. The aim of the present study was to investigate the effect of costunolide in OA treatment, using rat chondrocytes and an OA rat model, in which animals were subjected to destabilization of the medial meniscus. The results revealed that costunolide (2‑6 µM) had no effect on chondrocyte viability or phenotype maintenance. Costunolide decreased the interleukin (IL)‑1β‑induced upregulation of matrix metalloproteinases (MMPs), inducible nitric oxide synthase, cyclooxygenase‑2 and IL‑6, and increased the expression of collagen II and transcription factor SOX‑9, which were inhibited by IL‑1β. Costunolide significantly decreased p65 phosphorylation induced by IL‑1β and the translocation of p65 into the nucleus of rat chondrocytes, as observed by western blot analysis and immunofluorescence staining. In addition, activation of the Wnt/β‑catenin signaling pathway was inhibited by costunolide, as demonstrated by the level of activation of β‑catenin and the transfer of β‑catenin into the nucleus induced by IL‑1β. In vivo, cartilage treated with costunolide exhibited attenuated degeneration and lower Mankin scores compared with the OA group. The present study investigated the anti‑osteoarthritic effects of costunolide, which exerted anti‑inflammatory activities and inhibited MMPs expression. Taken together, these results indicate that costunolide may have a potential value in the treatment of OA.
View Figures
View References

Related Articles

Journal Cover

July-2019
Volume 20 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
He Y, Moqbel SA, Xu L, Ran J, Ma C, Xu K, Bao J, Jiang L, Chen W, Xiong Y, Xiong Y, et al: Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF‑κB and Wnt/β‑catenin signaling pathways. Mol Med Rep 20: 312-322, 2019
APA
He, Y., Moqbel, S.A., Xu, L., Ran, J., Ma, C., Xu, K. ... Wu, L. (2019). Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF‑κB and Wnt/β‑catenin signaling pathways. Molecular Medicine Reports, 20, 312-322. https://doi.org/10.3892/mmr.2019.10239
MLA
He, Y., Moqbel, S. A., Xu, L., Ran, J., Ma, C., Xu, K., Bao, J., Jiang, L., Chen, W., Xiong, Y., Wu, L."Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF‑κB and Wnt/β‑catenin signaling pathways". Molecular Medicine Reports 20.1 (2019): 312-322.
Chicago
He, Y., Moqbel, S. A., Xu, L., Ran, J., Ma, C., Xu, K., Bao, J., Jiang, L., Chen, W., Xiong, Y., Wu, L."Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF‑κB and Wnt/β‑catenin signaling pathways". Molecular Medicine Reports 20, no. 1 (2019): 312-322. https://doi.org/10.3892/mmr.2019.10239